Health Products

ADVIA CENTAUR SYSTEMS (2015-12-30)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
ending in 263 and above
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
B. ADVIA CENTAUR SYSTEM - PROSTATE-SPECIFIC ANTIGEN118157
ending in 263 and above
Manufacturer
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
A. ADVIA CENTAUR CP SYSTEM - PROSTATE-SPECIFIC ANTIGEN118156

Introduction

Affected Products 
  1. ADVIA CENTAUR CP SYSTEM - PROSTATE-SPECIFIC ANTIGEN
  2. ADVIA CENTAUR SYSTEM - PROSTATE-SPECIFIC ANTIGEN

Reason

Not meeting the current High-Dose Hook Effect expectation in the Instructions For Use (IFU). The ADVIA Centaur systems PSA assay range is 0.01-100 ng/mL (μg/L). The ADVIA Centaur Systems PSA IFU states that patient samples with high total PSA levels can cause a paradoxical decrease in the Relative Light Units (RLUs) (high-dose hook effect). In this assay, patient samples with total PSA levels as high as 10,000 ng/mL (μg /L) will assay greater than 100 ng/mL (μg/L).
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime